Medtronic, a leader in medical technology and Philips, a leader in health technology announced the signing of a Memorandum of ...

Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for ...

Medtronic announced that investigators enrolled the first patient in a pivotal trial of its Prevail drug-coated balloon (DCB) ...

The cardiovascular portfolio grew mid-single-digits, with cardiac ablation solutions reporting 22% growth, driven by the Pulse Field Ablation (PFA) products, Affera and PulseSelect. Management ...

Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025.

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for our fiscal '25 third-quarter video earnings webcast. Before we go inside to ...

Valve‐in‐valve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines and trials have ...

A Medtronic (NYSE: MDT) + official said today on LinkedIn that the company won CE mark for its Crescent RA jugular dual lumen catheter. Giuseppe Savoja, the medtech giant’s senior business ...

The global TAVR market ecosystem is composed of various stakeholders, including device manufacturers, hospitals, cardiologists, research institutions, and regulatory bodies. Key Manufacturers such as ...

However, since TAVR accounts for roughly 75% of Edwards ... Although Edwards has largely enjoyed a duopoly in aortic valves with Medtronic in the US, new competitors have begun to enter.

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...